DiscoverX Ponatinib
373,50 € HT
Ponatinib is an inhibitor of RIPK1, 2 and 3. Provided as 10mg of dry powder.
- Quantité
- 10 mg
- Marque
- DiscoverX
Ponatinib (or Iclusig) is typically used for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. It is intended to be effective against T315I mutated CML. Ponatinib is an inhibitor of multiple tyrosine kinases, including RIPK1, 2, and 3. Provided as 10mg of dry powder.
Caractéristiques techniques
| Marque | DiscoverX |
|---|---|
| Réf. B-LABO | BL-RE-170217 |
| Réf. fabricant | 17322629 |
| Quantité | 10 mg |
Une question, une configuration particulière ?
Contactez-nous pour un devis.
Contactez-nous pour un devis.
Produits similaires
